Recently, the European Journal of Breast Health published an international study conducted by the SIS members on breast cancer management during COVID-19 pandemic woldwide. This study found that :

• Breast cancer diagnosis and treatment were deeply impacted since the beginning of the SARS-CoV-2 pandemic.
• In the light of recent findings on COVID-19 risk among women with breast cancer, most of these changes should not be maintained as the risk of severe COVID-19 is related to comorbidities and age rather than breast cancer.
• Only women with breast cancer aged over 65 or with comorbidities require adaptation of their cancer management, according to the Senologic International Society.

Full text is available on PubMed or in pdf.